Lindbrook Capital, LLC Inovio Pharmaceuticals, Inc. Transaction History

Lindbrook Capital, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 26, 2023	BUY	$0.79 - $1.91 $432 - $1,046	548 Added 183.28%	847 $0
Q4 2022 Jan 24, 2023	BUY	$1.41 - $2.5 $248 - $440	176 Added 143.09%	299 $0
Q2 2022 Aug 01, 2022	SELL	$1.44 - $3.98 $1,000 - $2,766	-695 Reduced 84.96%	123 $0
Q1 2022 Apr 21, 2022	BUY	$2.97 - $5.2 $2,429 - $4,253	818 New	818 $3,000
Q4 2021 Jan 18, 2022	SELL	$4.99 - $7.46 $773 - $1,156	-155 Closed	0 $0
Q3 2021 Nov 05, 2021	SELL	$7.16 - $9.69 $1,159 - $1,569	-162 Reduced 51.1%	155 $1,000
Q2 2021 Jul 27, 2021	BUY	$6.23 - $10.03 $1,974 - $3,179	317 New	317 $3,000

281K

Ticker INO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 249,400,000
Market Cap $494M
Description
Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA se...

Get notified when there are updates to the investment portfolio of Lindbrook Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Lindbrook Capital, LLC with notifications on news.